Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
21.11
Oct 19 • 5:16 AM ET Dollar change-1.29 Percentage change(-5.74%)
Oct 16, 12:02 PMCity Therapeutics IPO debuts 27% above $18 offer after upsized $200M deal
Index
-
Market Cap
1.06B
Enterprise Value
-
Income
-
Sales
-
Book/sh
-
Cash/sh
-
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
-
IPO
Oct 16, 2026
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
-
Current Ratio
-
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / No
EPS (ttm)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
- -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
-
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
-
Insider Trans
-
Inst Own
11.70%
Inst Trans
-
ROA
-
ROE
-
ROIC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-2.96%
SMA50
-2.96%
SMA200
-2.96%
Trades
Shs Outstand
50.33M
Shs Float
-
52W High
23.88 -11.59%
52W Low
20.50 2.99%
Volatility
- -
ATR (14)
2.48
RSI (14)
-
Beta
-
Rel Volume
0.01
Avg Volume
1.41M
Volume
792
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
Perf YTD
-8.20%
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
22.40
Price
21.11
Change %
-5.74%
City Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the development of RNAi therapeutics. The company was founded by John Maraganore, Sebastian Trousil, Ari Nowacek, Mark Keating, Kotaro Nakanishi, Yukihide Tomari, and Phillip Zamore on July 17, 2023 and is headquartered in Cambridge, MA.
Ph.D.Dr. John Michael Maraganore M.D.
PresidentDr. Andrew C. Orth M.B.A.
Chief Scientific OfficerDr. Tracy Zimmermann Ph.D.
Ph.D.Dr. Baisong Mei M.D.
M.D.Dr. Ari Nowacek M.B.A.